Vertex Pharmaceuticals Inc (VRTX)
471.12
-4.86
(-1.02%)
USD |
NASDAQ |
Nov 01, 16:00
471.00
-0.12
(-0.03%)
After-Hours: 20:00
Vertex Pharmaceuticals Profit Margin (Quarterly): -135.8% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -135.8% |
| March 31, 2024 | 40.87% |
| December 31, 2023 | 38.48% |
| September 30, 2023 | 41.69% |
| June 30, 2023 | 36.73% |
| March 31, 2023 | 29.47% |
| December 31, 2022 | 35.56% |
| September 30, 2022 | 39.86% |
| June 30, 2022 | 36.90% |
| March 31, 2022 | 36.33% |
| December 31, 2021 | 37.16% |
| September 30, 2021 | 42.94% |
| June 30, 2021 | 3.74% |
| March 31, 2021 | 37.88% |
| December 31, 2020 | 37.12% |
| September 30, 2020 | 43.39% |
| June 30, 2020 | 54.92% |
| March 31, 2020 | 39.78% |
| December 31, 2019 | 41.27% |
| September 30, 2019 | 6.06% |
| June 30, 2019 | 28.41% |
| March 31, 2019 | 31.29% |
| December 31, 2018 | |
| September 30, 2018 | 16.41% |
| June 30, 2018 | 27.57% |
| Date | Value |
|---|---|
| March 31, 2018 | 32.81% |
| December 31, 2017 | 15.45% |
| September 30, 2017 | -17.81% |
| June 30, 2017 | 3.31% |
| March 31, 2017 | 34.66% |
| December 31, 2016 | 7.18% |
| September 30, 2016 | -9.39% |
| June 30, 2016 | -14.95% |
| March 31, 2016 | -10.46% |
| December 31, 2015 | -17.64% |
| September 30, 2015 | -30.71% |
| June 30, 2015 | -113.7% |
| March 31, 2015 | -143.4% |
| December 31, 2014 | -122.2% |
| September 30, 2014 | -95.01% |
| June 30, 2014 | -115.1% |
| March 31, 2014 | -196.2% |
| December 31, 2013 | 12.61% |
| September 30, 2013 | -55.99% |
| June 30, 2013 | -18.40% |
| March 31, 2013 | -93.80% |
| December 31, 2012 | -22.80% |
| September 30, 2012 | -17.13% |
| June 30, 2012 | -15.52% |
| March 31, 2012 | 20.88% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-135.8%
Minimum
Jun 2024
54.92%
Maximum
Jun 2020
28.33%
Average
37.88%
Median
Mar 2021
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| Bristol-Myers Squibb Co | 10.18% |
| Regeneron Pharmaceuticals Inc | 36.03% |
| Sarepta Therapeutics Inc | 1.78% |
| Moderna Inc | -578.7% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.96% |
| Return on Assets | -2.25% |
| Return on Invested Capital | -2.96% |
| Gross Profit Margin (Quarterly) | 85.94% |
| Operating Margin (Quarterly) | 35.34% |
| Return on Net Operating Assets | -8.40% |